Top

International Urogynecology Journal

Published in:

Open Access 01-05-2011 | Original Article

The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population

Authors: Tiny A. de Boer, Marijke C. P. Slieker-ten Hove, Curt W. Burger, Mark E. Vierhout

Published in: International Urogynecology Journal | Issue 5/2011

Abstract

Introduction and hypothesis

To study the prevalence and risk factors of overactive bladder (OAB) symptoms and its relationship with symptoms of pelvic organ prolapse (POP).

Methods

This is a cross-sectional study including women aged between 45 and 85 years, registered in eight general practices. All women were asked to self complete the validated Dutch translated questionnaires. All symptoms were dichotomized as present or absent based on responses to each symptom and degree of bother.

Results

Forty-seven percent of the women filled out the questionnaire. Prevalence of urgency was 34% and the prevalence of any OAB symptoms 49%. Prevalence of OAB symptoms increased with advancing age. Symptoms of POP were an independent risk factor for symptomatic OAB. Other risk factors were continence and prolapse surgery in the past, age above 75, overweight, postmenopausal status and smoking.

Conclusions

The prevalence of any OAB symptoms was 49%. POP symptoms were an independent risk factor for symptomatic OAB.

Digesu GA, Chaliha C, Salvatore S, Hutchings A, Khullar V (2005) The relationship of vaginal prolapse severity to symptoms and quality of life. BJOG 112(7):971–976PubMedCrossRef

Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89(4):501–506PubMedCrossRef

Temml C, Heidler S, Ponholzer A, Madersbacher S (2005) Prevalence of the overactive bladder syndrome by applying the International Continence Society definition. Eur Urol 48(4):622–627PubMedCrossRef

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van KP, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178PubMedCrossRef

de Boer TA, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P, Kirby MG, Koelbl H, Espuna-Pons M, Milsom I, Tubaro A, Wagg A, Vierhout ME (2010) Pelvic organ prolapse and overactive bladder. Neurourol Urodyn 29(1):30–39PubMedCrossRef

Slieker-ten Hove MC, Pool-Goudzwaard AL, Eijkemans MJ, Steegers-Theunissen RP, Burger CW, Vierhout ME (2009) Symptomatic pelvic organ prolapse and possible risk factors in a general population. Am J Obstet Gynecol 200(2):184–187PubMedCrossRef

Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA (1995) Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 14(2):131–139PubMedCrossRef

Lapitan MC, Chye PL (2001) The epidemiology of overactive bladder among females in Asia: a questionnaire survey. Int Urogynecol J Pelvic Floor Dysfunct 12(4):226–231PubMedCrossRef

Bump RC, Norton PA (1998) Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 25(4):723–746PubMedCrossRef

10.

Eva UF, Gun W, Preben K (2003) Prevalence of urinary and fecal incontinence and symptoms of genital prolapse in women. Acta Obstet Gynecol Scand 82(3):280–286PubMedCrossRef

11.

Samuelsson EC, Victor FT, Tibblin G, Svardsudd KF (1999) Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol 180(2 Pt 1):299–305PubMedCrossRef

12.

Abouassaly R, Steinberg JR, Lemieux M, Marois C, Gilchrist LI, Bourque JL, Tu lM, Corcos J (2004) Complications of tension-free vaginal tape surgery: a multi-institutional review. BJU Int 94(1):110–113PubMedCrossRef

13.

Tellez Martinez-Fornes M, Fernandez PC, Fouz LC, Fernandez LC, Borrego HJ (2009) A three year follow-up of a prospective open randomized trial to compare tension-free vaginal tape with Burch colposuspension for treatment of female stress urinary incontinence. Actas Urol Esp 33(10):1088–1096PubMedCrossRef

14.

Holmgren C, Nilsson S, Lanner L, Hellberg D (2007) Frequency of de novo urgency in 463 women who had undergone the tension-free vaginal tape (TVT) procedure for genuine stress urinary incontinence—a long-term follow-up. Eur J Obstet Gynecol Reprod Biol 132(1):121–125PubMedCrossRef

15.

Cheung WW, Khan NH, Choi KK, Bluth MH, Vincent MT (2009) Prevalence, evaluation and management of overactive bladder in primary care. BMC Fam Pract 10:8PubMedCrossRef

16.

Choo MS, Ku JH, Lee JB, Lee DH, Kim JC, Kim HJ, Lee JJ, Park WH (2007) Cross-cultural differences for adapting overactive bladder symptoms: results of an epidemiologic survey in Korea. World J Urol 25(5):505–511PubMedCrossRef

17.

Dallosso HM, McGrother CW, Matthews RJ, Donaldson MM (2003) The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 92(1):69–77PubMedCrossRef

18.

Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KM (2008) Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol 111(3):678–685PubMedCrossRef

19.

Teleman PM, Lidfeldt J, Nerbrand C, Samsioe G, Mattiasson A (2004) Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women. BJOG 111(6):600–604PubMedCrossRef

20.

Bradley CS, Kennedy CM, Nygaard IE (2005) Pelvic floor symptoms and lifestyle factors in older women. J Womens Health (Larchmt) 14(2):128–136CrossRef

21.

Nuotio M, Jylha M, Koivisto AM, Tammela TL (2001) Association of smoking with urgency in older people. Eur Urol 40(2):206–212PubMedCrossRef

22.

Baron JA (1984) Smoking and estrogen-related disease. Am J Epidemiol 119(1):9–22PubMed

23.

Hisayama T, Shinkai M, Takayanagi I, Toyoda T (1988) Mechanism of action of nicotine in isolated urinary bladder of guinea-pig. Br J Pharmacol 95(2):465–472PubMed

24.

Zhang W, Song Y, He X, Huang H, Xu B, Song J (2006) Prevalence and risk factors of overactive bladder syndrome in Fuzhou Chinese women. Neurourol Urodyn 25(7):717–721PubMedCrossRef

25.

Iosif CS, Batra S, Ek A, Astedt B (1981) Estrogen receptors in the human female lower uninary tract. Am J Obstet Gynecol 141(7):817–820PubMed

26.

Versi E, Harvey MA, Cardozo L, Brincat M, Studd JW (2001) Urogenital prolapse and atrophy at menopause: a prevalence study. Int Urogynecol J Pelvic Floor Dysfunct 12(2):107–110PubMedCrossRef

27.

Robinson D, Cardozo L (2010) New drug treatments for urinary incontinence. Maturitas 65(4):340–347PubMedCrossRef

28.

de Boer TA, Kluivers KB, Withagen MI, Milani AL, Vierhout ME (2010) Predictive factors for overactive bladder symptoms after pelvic organ prolapse surgery. Int Urogynecol J Pelvic Floor Dysfunct 21(9):1143–1149PubMedCrossRef

Title: The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population
Authors: Tiny A. de Boer
Marijke C. P. Slieker-ten Hove
Curt W. Burger
Mark E. Vierhout
Publication date: 01-05-2011
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 5/2011
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-010-1323-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2011

Bladder rupture associated with uterine rupture at delivery

Which factors determine subjective improvement following pelvic organ prolapse 1 year after surgery?

Site-specific prolapse surgery. I. Reliability and durability of native tissue paravaginal repair

Impact of Prolift procedure on bladder function and symptoms in women with pelvic organ prolapse

Bladder mass “collagenoma”

Site-specific prolapse surgery. II. Vaginal paravaginal repair augmented with either synthetic mesh or remodelling xenograft